Immune modulators as therapeutic agents for cutaneous T-cell lymphoma.
Alain H Rook, Bernice Benoit, Ellen J Kim, Carmela C Vittorio, Aleksandra Anshelevich, Brian A Raphael, Camille E Introcaso, Jennifer M Gardner, Katherine G Evans, Kelly Morrissey and 5 more
Article in Clinical lymphoma, myeloma & leukemia, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors at 2 institutions in 1 country.
Alain H RookDepartment of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia.
Bernice Benoit
Ellen J Kim
Carmela C Vittorio
Aleksandra Anshelevich
Brian A Raphael
Camille E Introcaso
Jennifer M Gardner
Katherine G Evans
Kelly Morrissey
Sara Samimi
Amy C Musiek
Louise C Showe
Mariusz A Wasik
Maria Wysocka
University of Pennsylvania · USThe Wistar Institute · US
Funding
Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Maureen E. Murphy · 1985 to 2026
$75.9M
Penn Dermatology Research Training ProgramT32AR007465 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI Elizabeth Anne Grice, David Joel Margolis · 1986 to 2026
$9.0M
CTCL STAGING USING GENE EXPRESSION PROFILESU01CA085060 · NCI · WISTAR INSTITUTE · PI SHOWE, LOUISE C · 1999 to 2003
$2.1M
HDAC Inhibitors and CTCLR01CA132098 · NCI · WISTAR INSTITUTE · PI SHOWE, LOUISE C. · 2009 to 2013
$2.0M
Microarray Analysis of Responsiveness of CTCL IL-12R01CA106553 · NCI · WISTAR INSTITUTE · PI SHOWE, LOUISE C. · 2004 to 2008
$1.4M
Comprehensive genomics using the Illumina Beadstation 500S10RR024693 · NCRR · WISTAR INSTITUTE · PI SHOWE, LOUISE C. · 2008 to 2008
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Immune modulators as therapeutic agents for cutaneous T-cell lymphoma. · full record | OpenQuestion